Sohaib Mir Ph.D Overview

  • Primary Position
  • Senior Investmen...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Sohaib Mir Ph.D General Information

Biography

Dr. Sohaib Mir serves as Senior Investment Principal at LifeArc Ventures. He serves as a Board Member at Maxion Therapeutics. He served as a Board Member at Montis Biosciences and Pheno Therapeutics. He brings more than 10 years of experience across investment banking and venture capital following a career in medicine. He was an Investment Director with ALSA Ventures, focused on therapeutics investing, a Principal at Cambridge Innovation Capital, and worked in healthcare M&A with Perella Weinberg Partners. He qualified in Medicine from the University of Birmingham where he also completed a PhD. He practiced medicine at Addenbrooke's Hospital in Cambridge and gained an MPhil in Bioscience Enterprise from the University of Cambridge.

Contact Information

Primary Position
Senior Investment Principal, LifeArc
Education
University of Cambridge, M.Phil (Master of Philosophy)
Birmingham University, MD (Doctor of Medicine)
Birmingham University, Ph.D. (Doctor of Philosophy)
Birmingham University, MS (Master of Science)
Gender
Male
Email
so
Phone
+44 01223
Address
  • Lynton House
  • 7-12 Tavistock Square
  • London WC1H 9LT
  • England, United Kingdom
+44 020

Sohaib Mir Ph.D Positions (2)

Firm name Firm type Title Location Industry Since
LifeArc Investor Senior Investment Principal London, United Kingdom Venture Capital
LifeArc Ventures Investor Senior Investment Principal London, United Kingdom Venture Capital

Sohaib Mir Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Maxion Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Pheno Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Edinburgh, United Kingdom

Sohaib Mir Ph.D Lead Partner on Deals (3)

Sohaib Mir Ph.D has been the lead partner on 3 deals. Their latest deal was with Maxion Therapeutics, a drug discovery company. The deal was made for on 03-Feb-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Maxion Therapeutics 03-Feb-2023 Early Stage VC Completed Drug Discovery Cambridge, United Kingdom
Montis Biosciences 01-Mar-2021 Completed Drug Discovery Leuven, Belgium
Pheno Therapeutics 29-Mar-2020 Completed Drug Discovery Edinburgh, United Kingdom

Sohaib Mir Ph.D Network (58)

Board Members (31)

Name Company Representing Location From
Ian Tomlinson Ph.D Maxion Therapeutics Self Cambridge, United Kingdom
Robert Tansley Exvastat Cambridge Innovation Capital Cambridge, United Kingdom
Pheno Therapeutics Pheno Therapeutics Edinburgh, United Kingdom
Maxion Therapeutics Monograph Capital Cambridge, United Kingdom
Maxion Therapeutics Monograph Capital Cambridge, United Kingdom

Portfolio Executives (15)

Name Company Role Deal date Location
Arndt Schottelius Ph.D Maxion Therapeutics Co-Chief Executive Officer 03-Feb-2023 Cambridge, United Kingdom
Aneesh Vellatt Ph.D Maxion Therapeutics Co-Founder, Chief Scientific Officer & Board Member 03-Feb-2023 Cambridge, United Kingdom
Maxion Therapeutics Co-Founder & Chief Technology Officer 03-Feb-2023 Cambridge, United Kingdom
Montis Biosciences Chief Executive Officer 01-Mar-2021 Leuven, Belgium
Montis Biosciences Acting Chief Medical Officer 01-Mar-2021 Leuven, Belgium

Fund Team Members (12)

Name Investor Fund Fund Location
Robert Balfour Ph.D ALSA Ventures ALSA Ventures Fund I London, United Kingdom
Jonathan Nash LifeArc Ventures LifeArc Ventures London, United Kingdom
ALSA Ventures London, United Kingdom
ALSA Ventures London, United Kingdom
ALSA Ventures London, United Kingdom

Sohaib Mir Ph.D Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
LifeArc Ventures LifeArc Ventures Venture Capital - Early Stage Evergreen
ALSA Ventures Fund I ALSA Ventures Venture - General Closed 2020

Sohaib Mir Ph.D FAQs

  • Who is Sohaib Mir Ph.D?

    Dr. Sohaib Mir serves as Senior Investment Principal at LifeArc Ventures.

  • How much does Sohaib Mir Ph.D typically invest?

    Sohaib Mir Ph.D's median deal size is .

  • What is Sohaib Mir Ph.D’s main position?

    Sohaib Mir Ph.D’s primary position is Senior Investment Principal.

  • What are the contact details for Sohaib Mir Ph.D?

    Sohaib Mir Ph.D’s email address is so and his phone number is +44 01223 .

  • How many active board seats does Sohaib Mir Ph.D hold?

    Sohaib Mir Ph.D holds 2 board seats including Maxion Therapeutics and Pheno Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »